Sampre Nutritions Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Sampre Nutritions Ltd. on BSE

Load latest

Sampre Nutritions Ltd.

28 Aug 2025

107.72

2.00%

Company Update

Sampre Nutritions Ltd - 530617 - Execution Of Manufacturing Agreement

BSE India

Execution of manufacturing contract to manufacture nutraceutical and food products as per agreed specifications and quality standards, to facilitate marketing, distribution and sale of such products.

pdf

Sampre Nutritions Ltd.

25 Aug 2025

107.72

2.00%

Board Meeting

Sampre Nutritions Ltd - 530617 - Board Meeting Outcome for To Appoint A Secretarial Auditor And …

BSE India

To appoint Neelu Goyal & Associates for a term of 5 consecutive years and to fix the date and time for the 34th annual general meeting of the company

pdf

Sampre Nutritions Ltd.

22 Aug 2025, 10:55PM

107.72

2.00%

Corp. Note

Sampre Nutritions Ltd - 530617 - Board Meeting Outcome for To Appoint The Secretarial Auditor Of …

BSE India

To appoint the secretarial auditor of the company for a term of 1 year for the financial year 2024-25

pdf

Sampre Nutritions Ltd.

22 Aug 2025, 10:46PM

107.72

2.00%

Board Meeting

Sampre Nutritions Ltd - 530617 - Board Meeting Intimation for To Fix The Date And Time …

BSE India

Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2025 ,inter alia, to consider and approve the date and time for the 34th Annual General Meeting of the Company

pdf

Sampre Nutritions Ltd.

22 Aug 2025, 10:37PM

107.72

2.00%

Company Update

Sampre Nutritions Ltd - 530617 - Execution Of Manufacturing Agreement

BSE India

Execution of manufacturing contract for manufacture, supply, quality assurance and packaging of nutraceutical and food products. The deal is expected to generate business revenues of INR 15 crores over the term of 3 years of the contract.

pdf

Sampre Nutritions Ltd.

20 Aug 2025

107.72

2.00%

Company Update

Sampre Nutritions Ltd - 530617 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

Resignation of Vinay Kumar Verma as the Non-Executive (Additional) Independent Director of the company from the close of business hours of Tuesday, 19 August 2025.

pdf

Sampre Nutritions Ltd.

20 Jul 2025

107.72

2.00%

Company Update

Sampre Nutritions Ltd - 530617 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

In compliance with Regulations 30 and 47 of the SEBI Listing Regulations 2015, newspaper publications of the QR code redirecting to the unaudited standalone and consolidated financial results with the limited review report for the first quarter ended 30 June 2025.

pdf

Sampre Nutritions Ltd.

18 Jul 2025

107.72

2.00%

Board Meeting

Sampre Nutritions Ltd - 530617 - Board Meeting Outcome for Board Meeting Outcome For Standalone And …

BSE India

In compliance with Regulation 30 read with Regulation 33 of the SEBI Listing Regulations, 2015, the standalone and consolidated unaudited financial results along with the limited review report from the statutory auditors of the company is attached for the first quarter ended 30 June 2025.

pdf

Sampre Nutritions Ltd.

15 Jul 2025

107.72

2.00%

Board Meeting

Sampre Nutritions Ltd - 530617 - Board Meeting Intimation for Unaudited Financial Results For The Quarter …

BSE India

Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2025 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results for the first quarter ended 30 June 2025

pdf

Sampre Nutritions Ltd.

10 Jul 2025

107.72

2.00%

Company Update

Sampre Nutritions Ltd - 530617 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Intimation to the BSE under Regulation 74(5) of the SEBI DP Regulations, 2018 with the certificate as received from the RTA for the quarter ended 30 June 2025.

pdf

Is Sampre Nutritions Ltd. worth buying?

28 Votes:

Buy 78.57%

Sell 14.29%

Hold 7.14%